Our innovative device helps to rapidly identify chemotherapy patients who are at risk of a life threatening complication called neutropenic sepsis.

​

Neutropenic sepsis prematurely takes tens of thousands of lives each year and costs healthcare systems tens of billions of dollars.

​

Through better triaging, Neutrocheck has the potential to save thousands of lives, free up valuable healthcare resources, and make patients'

lives easier, simpler, and better.